Ironwood Pharmaceuticals (IRWD)
(Delayed Data from NSDQ)
$6.30 USD
+0.24 (3.96%)
Updated May 31, 2024 04:00 PM ET
After-Market: $6.31 +0.01 (0.16%) 7:58 PM ET
4-Sell of 5 4
B Value B Growth F Momentum B VGM
Brokerage Reports
0 items in cart
Ironwood Pharmaceuticals, Inc. [IRWD]
Reports for Purchase
Showing records 161 - 180 ( 1019 total )
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology - Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Retail Prescription Sales Tracker - Constipation Drugs
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Retail Prescription Sales Tracker - Constipation Drugs
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Retail Prescription Sales Tracker - Constipation Drugs
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology - Recent Drug Launch Weekly Retail Sales Tracker - Week Ended February 22
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Strong Finish to 2018; Upgrade to Neutral; Raising Target to $14
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Retail Prescription Sales Tracker - Constipation Drugs
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Retail Prescription Sales Tracker - Constipation Drugs
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology - Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
FY18 Topline LINZESS Growth Stalls, but Margins Improve Ahead of Split 1H19
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology- Recent Drug Launch Weekly Retail Sales Tracker - Week Ended February 1
Provider: WEDBUSH SECURITIES INC.
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Retail Prescription Sales Tracker - Constipation Drugs
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Retail Prescription Sales Tracker - Constipation Drugs
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology - Recent Drug Launch Weekly Retail Sales Tracker - Week Ended January 25
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D